Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
200 | 3 | ONCOLOGY//PACLITAXEL//THYMIDYLATE SYNTHASE | 52806 |
1657 | 2 | FEBRILE NEUTROPENIA//METASTATIC BREAST CANCER//NEUTROPENIA | 7171 |
2226 | 1 | METASTATIC BREAST CANCER//VINORELBINE//CAPECITABINE | 2351 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | METASTATIC BREAST CANCER | authKW | 1924558 | 21% | 29% | 488 |
2 | VINORELBINE | authKW | 567325 | 9% | 21% | 201 |
3 | CAPECITABINE | authKW | 406139 | 9% | 14% | 218 |
4 | ADVANCED BREAST CANCER | authKW | 366946 | 5% | 24% | 112 |
5 | DOCETAXEL | authKW | 360641 | 13% | 9% | 315 |
6 | ANTHRACYCLINE RESISTANCE | authKW | 157676 | 1% | 59% | 20 |
7 | EPIRUBICIN | authKW | 108759 | 4% | 9% | 88 |
8 | SEMINARS IN ONCOLOGY | journal | 102862 | 9% | 4% | 200 |
9 | DOCETAXEL TAXOTERER | authKW | 98698 | 0% | 82% | 9 |
10 | NO ALBERTA BREAST CANC PROGRAM | address | 93827 | 0% | 100% | 7 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 73997 | 90% | 0% | 2116 |
2 | Pharmacology & Pharmacy | 745 | 13% | 0% | 299 |
3 | Obstetrics & Gynecology | 179 | 3% | 0% | 81 |
4 | Medicine, General & Internal | 39 | 4% | 0% | 87 |
5 | Dance | 14 | 0% | 0% | 1 |
6 | Health Care Sciences & Services | 14 | 1% | 0% | 23 |
7 | Health Policy & Services | 1 | 0% | 0% | 9 |
8 | Film, Radio, Television | 0 | 0% | 0% | 1 |
9 | Medicine, Research & Experimental | 0 | 1% | 0% | 33 |
10 | Medical Ethics | 0 | 0% | 0% | 1 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | NO ALBERTA BREAST CANC PROGRAM | 93827 | 0% | 100% | 7 |
2 | CANC THER Y DEV PROGRAM | 42891 | 0% | 80% | 4 |
3 | MED ONCOL | 36861 | 16% | 1% | 371 |
4 | BREAST CANC MED SERV | 32070 | 1% | 12% | 20 |
5 | BREAST ONCOL GRP | 30634 | 0% | 57% | 4 |
6 | MEDDON MONTI ONCOL | 30634 | 0% | 57% | 4 |
7 | BIOPATHOLU891 | 26808 | 0% | 100% | 2 |
8 | BIOSTATU891 | 26808 | 0% | 100% | 2 |
9 | CLIN ONCOL HEMATOL UNIT | 26808 | 0% | 100% | 2 |
10 | MED ONCOLU891 | 26808 | 0% | 100% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | SEMINARS IN ONCOLOGY | 102862 | 9% | 4% | 200 |
2 | ANNALS OF ONCOLOGY | 37937 | 7% | 2% | 155 |
3 | BREAST CANCER RESEARCH AND TREATMENT | 28451 | 5% | 2% | 126 |
4 | JOURNAL OF CLINICAL ONCOLOGY | 27166 | 8% | 1% | 183 |
5 | ONCOLOGY | 25902 | 4% | 2% | 88 |
6 | CLINICAL BREAST CANCER | 23618 | 2% | 5% | 38 |
7 | ANTI-CANCER DRUGS | 20695 | 3% | 2% | 72 |
8 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 17390 | 3% | 2% | 73 |
9 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 14059 | 4% | 1% | 89 |
10 | ONCOLOGY-NEW YORK | 10216 | 1% | 2% | 34 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | METASTATIC BREAST CANCER | 1924558 | 21% | 29% | 488 | Search METASTATIC+BREAST+CANCER | Search METASTATIC+BREAST+CANCER |
2 | VINORELBINE | 567325 | 9% | 21% | 201 | Search VINORELBINE | Search VINORELBINE |
3 | CAPECITABINE | 406139 | 9% | 14% | 218 | Search CAPECITABINE | Search CAPECITABINE |
4 | ADVANCED BREAST CANCER | 366946 | 5% | 24% | 112 | Search ADVANCED+BREAST+CANCER | Search ADVANCED+BREAST+CANCER |
5 | DOCETAXEL | 360641 | 13% | 9% | 315 | Search DOCETAXEL | Search DOCETAXEL |
6 | ANTHRACYCLINE RESISTANCE | 157676 | 1% | 59% | 20 | Search ANTHRACYCLINE+RESISTANCE | Search ANTHRACYCLINE+RESISTANCE |
7 | EPIRUBICIN | 108759 | 4% | 9% | 88 | Search EPIRUBICIN | Search EPIRUBICIN |
8 | DOCETAXEL TAXOTERER | 98698 | 0% | 82% | 9 | Search DOCETAXEL+TAXOTERER | Search DOCETAXEL+TAXOTERER |
9 | PACLITAXEL | 93007 | 9% | 3% | 210 | Search PACLITAXEL | Search PACLITAXEL |
10 | ORAL VINORELBINE | 83673 | 1% | 39% | 16 | Search ORAL+VINORELBINE | Search ORAL+VINORELBINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |